Anixa Biosciences
ANIX
60 hedge funds and large institutions have $13.1M invested in Anixa Biosciences in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 17 closing their positions.
5,840% more call options, than puts
Call options by funds: $297K | Put options by funds: $5K
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
2.12% less ownership
Funds ownership: 17.3% → 15.18% (-2.1%)
15% less funds holding
Funds holding: 71 → 60 (-11)
26% less capital invested
Capital invested by funds: $17.8M → $13.1M (-$4.63M)
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$393K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$274K |
| 3 |
Vontobel Holding
Zurich,
Switzerland
|
+$88.8K |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$74K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$49.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWM
Mission Wealth Management
Santa Barbara,
California
|
-$646K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$452K |
| 3 |
6CM
683 Capital Management
New York
|
-$355K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$293K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$186K |
ANIX Hedge Fund Activity: Q1 2026 in Review
60 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2026, worth a combined $13.1M — down 26% from $17.8M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ANIX and 9 opened new positions — a net loss of 8 holders — while 10 trimmed existing stakes and 15 added.
The largest buyer was Marshall Wace, adding an estimated $393K. The largest seller was Mission Wealth Management, exiting entirely with an estimated $646K sold.
- 60 institutional investors held Anixa Biosciences (ANIX) as of Q1 2026, down from 71 in Q4 2025.
- Funds reported $13.1M of Anixa Biosciences stock for Q1 2026, down 26% quarter-over-quarter.
- 9 funds opened new Anixa Biosciences positions in Q1 2026 and 17 closed out, a net change of -8 holders.
- The largest Anixa Biosciences buyer in Q1 2026 was Marshall Wace, an estimated $393K added.
- The largest Anixa Biosciences seller in Q1 2026 was Mission Wealth Management, an estimated $646K sold.
Based on aggregated 13F filings for Q1 2026.